NON-FAMILIAL HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA
Clinical trials for NON-FAMILIAL HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new NON-FAMILIAL HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA trials appear
Sign up with your email to follow new studies for NON-FAMILIAL HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cholesterol drug shows promise in phase 3 trial
Disease control Recruiting nowThis study tests a new medicine called IBI306 in people with high cholesterol that is not inherited. The goal is to see if it safely lowers 'bad' LDL cholesterol more than a placebo. About 198 adults in China will take the drug or a placebo for 12 weeks while keeping a healthy li…
Matched conditions: NON-FAMILIAL HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA
Phase: PHASE3 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New shot could tame stubborn high cholesterol
Disease control Recruiting nowThis study tests a new medicine called SYH2053, given as a shot under the skin, to see if it safely lowers 'bad' LDL cholesterol in people with high cholesterol or mixed lipid problems. About 760 adults whose cholesterol is not at goal will receive either the drug or a placebo. T…
Matched conditions: NON-FAMILIAL HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA
Phase: PHASE3 • Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:51 UTC